Although BRCA2 function is often restricted to DNA recombination and repair, evidence is accumulating that the silencing of this gene might be of particular importance in the pathogenesis of a significant proportion of sporadic breast cancers. This evidence concerns the gene BRCA2 and breast carcinoma.